These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2859870)

  • 21. The combination of nifedipine and propranolol in the management of patients with angina pectoris.
    Tweddel AC; Beattie JM; Murray RG; Hutton I
    Br J Clin Pharmacol; 1981 Aug; 12(2):229-33. PubMed ID: 7030373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alinidine in angina.
    Meinertz T; Kasper W; Meier R; Wiegand U; Bechtold H; Förster I; Pop T; Jähnchen E
    Clin Pharmacol Ther; 1983 Dec; 34(6):770-6. PubMed ID: 6641092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris.
    Sheridan JV; Thomas P; Routledge PA; Sheridan DJ
    Br J Clin Pharmacol; 1987 Apr; 23(4):391-6. PubMed ID: 3107605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
    Marshall AJ; Kettle MA; Barritt DW
    Br J Clin Pharmacol; 1980 Sep; 10(3):217-21. PubMed ID: 7437237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term indoramin therapy in congestive heart failure: a double-blind, randomized, parallel placebo-controlled trial.
    Leier CV; Binkley PF; Randolph PH; Unverferth DV
    J Am Coll Cardiol; 1987 Feb; 9(2):426-32. PubMed ID: 3543093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-adrenergic coronary constriction in effort angina.
    Berkenboom G; Unger P
    Basic Res Cardiol; 1990; 85 Suppl 1():359-69. PubMed ID: 1965403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of doxazosin on exercise-induced angina pectoris, ST-segment depression, and insulin sensitivity in patients with syndrome X.
    Bøtker HE; Sonne HS; Schmitz O; Nielsen TT
    Am J Cardiol; 1998 Dec; 82(11):1352-6. PubMed ID: 9856918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
    Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
    Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris.
    Giles TD; Iteld BJ; Quiroz AC; Mautner RK
    Chest; 1981 Aug; 80(2):142-5. PubMed ID: 7018846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gallopamil in chronic stable angina: antianginal effect and mechanism of action. A randomized, placebo-controlled, double-blind, cross-over trial.
    Zanolla L; Carbonieri E; Rossi L; Marino P; Zardini P
    Cardiology; 1992; 80(5-6):324-31. PubMed ID: 1451119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
    Antani J; Buckle JW; Turner J; Cohen M
    Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
    Jonker JJ; de Klerk J; den Ottolander GJ
    Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of exercise-induced ST-segment depression in patients without typical angina pectoris.
    Sundkvist GM; Hjemdahl P; Kahan T; Melcher A
    J Intern Med; 2007 Feb; 261(2):148-58. PubMed ID: 17241180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indoramin in the hypertensive patient with concomitant disease: clinical experience.
    Rosendorff C
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S93-7. PubMed ID: 2423808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability of response to beta receptor blockade for angina pectoris in clinical trials: a study of pindolol.
    Harston WE; Friesinger GC
    Am J Cardiol; 1982 Oct; 50(4):722-7. PubMed ID: 6127028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris.
    Burian M; Piske M; Petkovic D; Mitrovic V
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):37-46. PubMed ID: 15115902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.